Sesame oil attenuates cisplatin-induced hepatic and renal injuries by inhibiting nitric oxide-associated lipid peroxidation in mice

Shock

Volumn 27, Issue 2, 2007, Pages 199-204

  Hsu, Dur Zong ^a   Chen, Ke Ting ^a   Lin, Ta Hsing ^a   Li, Ya Hui ^a   Liu, Ming Yie ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cisplatin; Lipid peroxidation; Organ damage; Sesame oil; Tumor

Indexed keywords

CISPLATIN; HYDROXYL RADICAL; NITRIC OXIDE; NITRITE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SESAME SEED OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG POTENCY; FEMALE; KIDNEY INJURY; LIPID PEROXIDATION; LIVER INJURY; MELANOMA; MOUSE; NONHUMAN; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; KIDNEY; LIPID PEROXIDATION; LIVER; MELANOMA; MICE; NITRIC OXIDE; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SESAME OIL;

EID: 33846245439     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000238063.54332.06     Document Type: Article

References (38)

1. Kadikoylu G, Bolanam Z, Demir S, Balkaya M, Akalin N, Enli Y: The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys. Hum Exp Toxicol 23:29-34, 2004.
2. Cavalli F, Tschopp L, Sonntag RW, Zimmerman A: A case of liver toxicity following cis-dichlorodiammineplatinum (II) treatment. Cancer Treat Rep 62:2125-2126, 1987.
3. Madias NE, Marrington JT: Platinum nephrotoxicity. Am J Med 65:307-314, 1978.
4. Plooera CF, Meglio F, Nardi M, Vitelli G, Morolla P: Cisplatin-induced hepatic toxicity. J Clin Oncol 5:318-319, 1987.
5. Cersosimo RJ: Hepatotoxicity associated with cisplatin chemotherapy. Ann Pharm 27:438-441, 1993.
6. Yoshida M, Itzuka K, Hara M, Nishijima H, Shimada A, Nakada K, Satoh Y, Akama Y, Terada A: Prevention of nephrotoxicity of cisplatin by repeated oral administration of ebselen in rats. Tohoku J Exp Med 191:209-220, 2000.
7. Weijl NI, Cleton FJ, Osanto S: Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23:209-240, 1997.
8. Antunes LMG, Darin JD, Bianchi MD: Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res 41:405-411, 2000.
9. Antunes LM, Darin JDC, Bianchi NL: Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res 43:145-150, 2001.
10. Mora LO, Antunes LM, Franceskocato HDC, Bianchi ML: The effects of oral glutamine on cisplatin-induced nephrotoxicity in rats. Pharmacol Res 47:511-522, 2003.
11. Aoyagi K, Akiyama K, Shahrzad S, Tomida C, Hirayama A, Nagase S, Takemura K, Koyama A, Ohba S, Narita M: Formation of guanidinosuccinic acid, a stable nitric oxide mimic, from argininosuccinic acid and nitric oxide-derived free radicals. Free Radic Res 31:59-65, 1999.
12. Dalloz F, Maupoil V, Lecour S, Briot F, Rochette L: In vitro studies of interactions of NO donor drugs with superoxide and hydroxyl radicals. Mol Cell Biochem 177:193-200, 1997.
13. Obata T: Nitric oxide and depolarization induce hydroxyl radical generation. Jpn J Pharmacol 88:1-5, 2002.
14. Sugano M, Akimoto KA: Multifunctional gift from nature. J Chin Nutr Soc 18:1-11, 1993.
15. Simon JE, Chadwick AF, Craker LE: Herbs: an indexed bibliography 1971-1980. The scientific literature on selected herbs, and aromatic and medicinal plants of the temperate zone. Hamden, CT: Archon Book, 1984. Available at: http://www.hort.purdue.edu/newcrop/med-aro/factsheets/SESAME. html. Accessed January 11, 2002.
16. Samhita C: Sharma P (ed.) and translator: Text with English Translation. Varanasi, India: Chaukambha Orientalia Publisher, 1981.
17. Schneider RH, Cavanaugh KL, Kasture HS, Rothernberg S, Averbach R, Robinson D, Wallace RK: Health promotion with a traditional system of natural health care: Maharishi Ayur-Veda. J Soc Behav Pers 3:1-27, 1990.
18. Hirose N, Doi F, Ueki T, Akazawa K, Chijiiwa K, Sugano M, Akimoto K, Shimizu S, Yamada H: Suppressive effect of sesamin against 7,12- dimethylbenz[α]-anthracene induced rat mammary carcinogenesis. Anticancer Res 12:1259-1265, 1992.
19. Kaur IP, Saini A: Sesamol exhibits antimutagenic activity against oxygen species mediated mutagenicity. Mutat Res 470:71-76, 2000.
20. Hsu DZ, Liu MY: Sesame oil protects against lipopolysaccharide-stimulated oxidative stress in rats. Crit Care Med 32:227-231, 2004.
21. 2-mediated reduction of pulmonary metastases and augmentation of immunocompetence in C57BL/6 mice bearing B16-melanoma. J Immunother 22:103-113, 1999.
22. Sewerynek E, Melchiorri D, Reiter RJ, Ortiz GG, Lewinski A: Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 293:327-334, 1995.
23. Hsu DZ, Liu MY: Sesame oil attenuates multiple organ failure and increases survival rate during endotoxemia in rats. Crit Care Med 30:1859-1862, 2002.
24. Tsai CH, Stern A, Chiou JF, Chern CL, Liu TZ: Rapid and specific detection of hydroxyl radical using an ultraweak chemiluminescence analyzer and a low-level chemiluminescence emitter: application to hydroxyl radical-scavenging ability of aqueous extracts of food constituents. J Agric Food Chem 49:2137-2141, 2001.
25. Chen SL, Jian LE, Lang HQ: Optimization of peroxynitrite-luminal chemiluminescence system for detecting peroxynitrite in cell culture solution exposed to carbon disulphide. Luminescence 18:249-253, 2003.
26. Green LC, Ruiz LK, Wagner DA, Rand W, Istfan N, Young VR, Tannenbaum SR: Nitrate biosynthesis in man. Proc Natl Acad Sci U S A 78:7764-7768, 1981.
27. Sharkey EM, O'Neill HB, Kavarana MJ, Wang H, Creighton DJ, Sentz DL, Eiseman JL: Pharmacokinetics and antitumor properties in tumor-bearing mice of an enediol analogue inhibitor of glyoxalase I. Cancer Chemother Pharmacol 46:156-166, 2000.
28. Baliga R, Ueda N, Walker PD, Shah SV: Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 31:971-997, 1999.
29. Davis CA, Nick HS, Agarwal A: Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol 12:2683-2690, 2001.
30. Dillioglugil MO, Maral KH, Gulkac MD, Ozon KA, Ozdogan HK, Acar O, Dillioglugil O: Protective effects of increasing vitamin E and A doses on cisplatin-induced oxidative damage to kidney tissue in rats. Urol Int 75:340-344, 2005.
31. Lee JE, Nakagawa T, Kim TS, Endo T, Shiga A, Iguchi F, Lee SH, Ito J: Role of reactive radicals in degeneration of the auditory system of mice following cisplatin treatment. Acta Otolaryngol 124:1131-1135, 2004.
32. Srivastava RC, Farookh A, Ahmad N, Misra M, Hasan SK, Husain MM: Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats. Biometals 9:139-142, 1996.
33. Kelly TC, Whitworth CA, Husain K, Rybak LP: Aminoguanidine reduces cisplatin ototoxicity. Hear Res 186:10-16, 2003.
34. Brown SJ, Kellett PJ, Lippard SJ: Ixr-1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science 261:603-605, 1993.
35. Fink D, Aebi S, Howell SB: The role of DNA mismatch repair in drug resistance. Clin Cancer Res 4:1-6, 1998.
36. Goddard PM, Orr RM, Valenti MR, Barnard CF, Murrer BA, Kelland LR, Harrap KR: Novel trans platinum complex: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumors. Anticancer Res 16:33-38, 1996.
37. Drewa T, Wozniak A, Drewa G, Olszewska D, Wozniak BG, Wysocki M, Szlyk E, Lakomska A: Effect of novel platinum complexes on survival rate of B16 and Cl S91 melanoma cells and oxidation stress in vitro. Med Sci Monit 7:680-686, 2001.
38. Matteucci C, Grelli S, De Smaele E, Fontana C, Mastino A: Identification of nuclei from apoptotic, necrotic and viable lymphoid cells by using multiparameter flow cytometry. Cytometry 35:145-153, 1999.